Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment

NCT07277361 is registered in ClinicalTrials.gov with Wladimir MAUHIN, Dr as lead sponsor.

NCT NCT07277361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07277361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific Treatment
Lead sponsor
Wladimir MAUHIN, Dr
Phase
Observational
Overall status
Recruiting
Start date
October 8, 2024
Completion date
October 14, 2031
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aged 65 years or older, alpha galactosidase a deficiency, fabry disease, galactosidase a gene mutation